CDK 4/6 inhibitor-associated hematologic toxicities and febrile neutropenia in patients with hormone receptor-positive HER2-negative metastatic breast cancer

Category Systematic review
JournalJNCCN Journal of the National Comprehensive Cancer Network
Year 2019
This article has no abstract
Epistemonikos ID: cda6f5ce2ef1a3ccb8bbc2ac0fbdc1ae73be4125
First added on: Feb 11, 2025